0001365916-20-000140.txt : 20200807
0001365916-20-000140.hdr.sgml : 20200807
20200807195739
ACCESSION NUMBER: 0001365916-20-000140
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200805
FILED AS OF DATE: 20200807
DATE AS OF CHANGE: 20200807
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Piwnica Carole
CENTRAL INDEX KEY: 0001501760
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34885
FILM NUMBER: 201086294
MAIL ADDRESS:
STREET 1: C/O AMYRIS, INC.
STREET 2: 5885 HOLLIS ST., SUITE 100
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AMYRIS, INC.
CENTRAL INDEX KEY: 0001365916
STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL ORGANIC CHEMICALS [2860]
IRS NUMBER: 550856151
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5885 HOLLIS STREET, SUITE 100
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
BUSINESS PHONE: 510-450-0761
MAIL ADDRESS:
STREET 1: 5885 HOLLIS STREET, SUITE 100
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
FORMER COMPANY:
FORMER CONFORMED NAME: AMYRIS BIOTECHNOLOGIES INC
DATE OF NAME CHANGE: 20060613
4
1
wf-form4_159684463830197.xml
FORM 4
X0306
4
2020-08-05
0
0001365916
AMYRIS, INC.
AMRS
0001501760
Piwnica Carole
C/O AMYRIS, INC.
5885 HOLLIS STREET, SUITE 100
EMERYVILLE
CA
94608
1
0
0
0
Common Stock
2020-08-05
4
A
0
2266
0
A
10064
D
Common Stock
1372634
I
by Naxyris S.A.
Warrant (Right to Buy)
4.94
2020-08-05
4
A
0
3466
0
A
2030-08-05
Common Stock
3466.0
3466
D
Represents a restricted stock unit award that vests as to 100% of the units on August 5, 2021.
Includes an additional 2,266 shares of common stock beneficially owned by the Reporting Person as reported on the Form 4 filed on October 25, 2019. Due to an unintentional error, the Form 5 filed by the Reporting Person on April 7, 2020 included the wrong number of shares beneficially owned by the Reporting Person.
The Reporting Person beneficially owns securities held by Naxyris S.A. since August 22, 2019.
Stock option vests as to 100% of the shares underlying the stock option on August 5, 2021.
/s/ Carole Piwnica by Bruna Lawant, Attorney-in-Fact
2020-08-05